Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii

Introduction Acinetobacter baumannii has attained an alarming level of resistance to antibacterial drugs. Clinicians are now considering the use of older agents or unorthodox combinations of licensed drugs against multidrug-resistant strains to bridge the current treatment gap. We investigated the i...

Full description

Bibliographic Details
Main Authors: Bin Liu, Youning Liu, Xiuzhen Di, Xin Zhang, Rui Wang, Yan Bai, Jin Wang
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT) 2014-07-01
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822014000400451&lng=en&tlng=en
_version_ 1811232382693408768
author Bin Liu
Youning Liu
Xiuzhen Di
Xin Zhang
Rui Wang
Yan Bai
Jin Wang
author_facet Bin Liu
Youning Liu
Xiuzhen Di
Xin Zhang
Rui Wang
Yan Bai
Jin Wang
author_sort Bin Liu
collection DOAJ
description Introduction Acinetobacter baumannii has attained an alarming level of resistance to antibacterial drugs. Clinicians are now considering the use of older agents or unorthodox combinations of licensed drugs against multidrug-resistant strains to bridge the current treatment gap. We investigated the in vitro activities of combination treatments that included colistin with vancomycin, norvancomycin or linezolid against multidrug-resistant Acinetobacter baumannii. Methods The fractional inhibitory concentration index and time-kill assays were used to explore the combined effects of colistin with vancomycin, norvancomycin or linezolid against 40 clinical isolates of multidrug-resistant Acinetobacter baumannii. Transmission electron microscopy was performed to evaluate the interactions in response to the combination of colistin and vancomycin. Results The minimum inhibitory concentrations (MICs) of vancomycin and norvancomycin for half of the isolates decreased below the susceptibility break point, and the MIC of linezolid for one isolate was decreased to the blood and epithelial lining fluid concentration using the current dosing regimen. When vancomycin or norvancomycin was combined with subinhibitory doses of colistin, the multidrug-resistant Acinetobacter baumannii test samples were eradicated. Transmission electron microscopy revealed that subinhibitory doses of colistin were able to disrupt the outer membrane, facilitating a disruption of the cell wall and leading to cell lysis. Conclusions Subinhibitory doses of colistin significantly enhanced the antibacterial activity of vancomycin, norvancomycin, and linezolid against multidrug-resistant Acinetobacter baumannii.
first_indexed 2024-04-12T11:02:14Z
format Article
id doaj.art-37e537938c2b49c9a7944bcec3b1f8df
institution Directory Open Access Journal
issn 1678-9849
language English
last_indexed 2024-04-12T11:02:14Z
publishDate 2014-07-01
publisher Sociedade Brasileira de Medicina Tropical (SBMT)
record_format Article
series Revista da Sociedade Brasileira de Medicina Tropical
spelling doaj.art-37e537938c2b49c9a7944bcec3b1f8df2022-12-22T03:35:55ZengSociedade Brasileira de Medicina Tropical (SBMT)Revista da Sociedade Brasileira de Medicina Tropical1678-98492014-07-0147445145610.1590/0037-8682-0081-2014S0037-86822014000400451Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumanniiBin LiuYouning LiuXiuzhen DiXin ZhangRui WangYan BaiJin WangIntroduction Acinetobacter baumannii has attained an alarming level of resistance to antibacterial drugs. Clinicians are now considering the use of older agents or unorthodox combinations of licensed drugs against multidrug-resistant strains to bridge the current treatment gap. We investigated the in vitro activities of combination treatments that included colistin with vancomycin, norvancomycin or linezolid against multidrug-resistant Acinetobacter baumannii. Methods The fractional inhibitory concentration index and time-kill assays were used to explore the combined effects of colistin with vancomycin, norvancomycin or linezolid against 40 clinical isolates of multidrug-resistant Acinetobacter baumannii. Transmission electron microscopy was performed to evaluate the interactions in response to the combination of colistin and vancomycin. Results The minimum inhibitory concentrations (MICs) of vancomycin and norvancomycin for half of the isolates decreased below the susceptibility break point, and the MIC of linezolid for one isolate was decreased to the blood and epithelial lining fluid concentration using the current dosing regimen. When vancomycin or norvancomycin was combined with subinhibitory doses of colistin, the multidrug-resistant Acinetobacter baumannii test samples were eradicated. Transmission electron microscopy revealed that subinhibitory doses of colistin were able to disrupt the outer membrane, facilitating a disruption of the cell wall and leading to cell lysis. Conclusions Subinhibitory doses of colistin significantly enhanced the antibacterial activity of vancomycin, norvancomycin, and linezolid against multidrug-resistant Acinetobacter baumannii.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822014000400451&lng=en&tlng=enAcinetobacter baumanniiColistinCombinationLinezolidMultidrug-resistantVancomycin
spellingShingle Bin Liu
Youning Liu
Xiuzhen Di
Xin Zhang
Rui Wang
Yan Bai
Jin Wang
Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii
Revista da Sociedade Brasileira de Medicina Tropical
Acinetobacter baumannii
Colistin
Combination
Linezolid
Multidrug-resistant
Vancomycin
title Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii
title_full Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii
title_fullStr Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii
title_full_unstemmed Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii
title_short Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii
title_sort colistin and anti gram positive bacterial agents against acinetobacter baumannii
topic Acinetobacter baumannii
Colistin
Combination
Linezolid
Multidrug-resistant
Vancomycin
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822014000400451&lng=en&tlng=en
work_keys_str_mv AT binliu colistinandantigrampositivebacterialagentsagainstacinetobacterbaumannii
AT youningliu colistinandantigrampositivebacterialagentsagainstacinetobacterbaumannii
AT xiuzhendi colistinandantigrampositivebacterialagentsagainstacinetobacterbaumannii
AT xinzhang colistinandantigrampositivebacterialagentsagainstacinetobacterbaumannii
AT ruiwang colistinandantigrampositivebacterialagentsagainstacinetobacterbaumannii
AT yanbai colistinandantigrampositivebacterialagentsagainstacinetobacterbaumannii
AT jinwang colistinandantigrampositivebacterialagentsagainstacinetobacterbaumannii